Tehran University of Medical Sciences

Science Communicator Platform

Share By
Fluoxetine for Multiple Sclerosis Publisher



Hosseini R1 ; Tajdini M2 ; Modabbernia A3 ; Akhondzadeh S4 ; Tafakhori A5
Authors

Source: Cochrane Database of Systematic Reviews Published:2018


Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The objectives of this review is to assess the efficacy and safety of fluoxetine to modify the course of the disease in people with multiple sclerosis. © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
1. Improving Adverse Drug Event Reporting by Health Care Professionals, Cochrane Database of Systematic Reviews (2017)
3. Stem Cell Therapy for Multiple Sclerosis, Cochrane Database of Systematic Reviews (2018)
Experts (# of related papers)
Other Related Docs
4. Antibiotics for Induction of Remission in Ulcerative Colitis, Cochrane Database of Systematic Reviews (2020)
7. Interventions for Cutaneous Lichen Planus, Cochrane Database of Systematic Reviews (2018)
10. Povidone-Iodine for Transrectal Prostate Biopsy, Cochrane Database of Systematic Reviews (2025)
13. Vaccines for Preventing Cutaneous Leishmaniasis, Cochrane Database of Systematic Reviews (2018)
18. Statins in Adult Patients With Hiv, Medicine (United States) (2018)